Biggest changeOur results of operations are reported as one business segment, represented by our single operating segment. For the year ended December 31, Change 2024 2023 Period to Period (dollars in thousands) Net sales $ 717,301 100 % $ 666,435 100 % $ 50,866 8 % Cost of sales 413,296 58 % 381,376 57 % 31,920 8 % Gross profit 304,005 42 % 285,059 43 % 18,946 7 % Operating expenses, net: Research and development 124,507 17 % 112,853 17 % 11,654 10 % Selling, general, and administrative 99,663 14 % 92,756 14 % 6,907 7 % Amortization of intangible assets 6,983 1 % 8,481 1 % (1,498) (18) % Asset impairment 28,131 4 % — — % 28,131 * Other operating expense (income), net (22,260) (3) % 1,029 — % (23,289) * % Total operating expenses, net 237,024 33 % 215,119 32 % 21,905 10 % Operating income 66,981 9 % 69,940 10 % (2,959) (4) % Interest income (expense), net 1,853 0 % (1,187) (0) % 3,040 * % Other income (expense), net — — % (97,091) (15) % 97,091 * Income (loss) before income taxes 68,834 10 % (28,338) (4) % 97,172 * Income tax expense (benefit) (4,880) (1) % 2,030 — % (6,910) * Net income (loss) $ 73,714 10 % $ (30,368) (5) % $ 104,082 * * Not meaningful Net Sales The following is an analysis of sales by end-market and by region: Year ended December 31, Change 2024 2023 Period to Period (dollars in thousands) Sales by end-market Semiconductor $ 466,611 65 % $ 412,724 62 % $ 53,887 13 % Compound Semiconductor 77,591 11 % 87,258 13 % (9,667) (11) % Data Storage 98,852 14 % 88,473 13 % 10,379 12 % Scientific & Other 74,247 10 % 77,980 12 % (3,733) (5) % Total $ 717,301 100 % $ 666,435 100 % $ 50,866 8 % Sales by geographic region United States $ 164,564 23 % $ 162,790 24 % $ 1,774 1 % EMEA 61,730 9 % 76,697 12 % (14,967) (20) % China 255,619 36 % 217,942 33 % 37,677 17 % Rest of APAC 234,591 32 % 208,693 31 % 25,898 12 % Rest of World 797 — % 313 — % 484 155 % Total $ 717,301 100 % $ 666,435 100 % $ 50,866 8 % 35 Table of Contents Total sales increased for the year ended December 31, 2024 against the comparable prior year period in the Semiconductor and Data Storage markets, partially offset by a decrease in the Compound Semiconductor, and Scientific & Other markets.
Biggest changeOur results of operations are reported as one business segment, represented by our single operating segment. For the year ended December 31, Change 2025 2024 Period to Period (dollars in thousands) Net sales $ 664,294 100 % $ 717,301 100 % $ (53,007) (7) % Cost of sales 398,885 60 % 413,296 58 % (14,411) (3) % Gross profit 265,409 40 % 304,005 42 % (38,596) (13) % Operating expenses, net: Research and development 119,641 18 % 124,507 17 % (4,866) (4) % Selling, general, and administrative 98,906 15 % 99,663 14 % (757) (1) % Amortization of intangible assets 3,136 0 % 6,983 1 % (3,847) (55) % Merger costs 8,908 1 % — — % 8,908 * Asset impairment — — % 28,131 4 % (28,131) * Other operating expense (income), net (889) (0) % (22,260) (3) % 21,371 (96) % Total operating expenses, net 229,702 35 % 237,024 33 % (7,322) (3) % Operating income 35,707 5 % 66,981 9 % (31,274) (47) % Interest income, net 4,333 1 % 1,853 0 % 2,480 * Other income (expense), net (653) (0) % — — % (653) * Income before income taxes 39,387 6 % 68,834 10 % (29,447) * Income tax expense (benefit) 3,997 1 % (4,880) (1) % 8,877 * Net income $ 35,390 5 % $ 73,714 10 % $ (38,324) * * Not meaningful Net Sales The following is an analysis of sales by end-market and by region: Year ended December 31, Change 2025 2024 Period to Period (dollars in thousands) Sales by end-market Semiconductor $ 476,559 72 % $ 466,611 65 % $ 9,948 2 % Compound Semiconductor 59,557 9 % 77,591 11 % (18,034) (23) % Data Storage 39,238 6 % 98,852 14 % (59,614) (60) % Scientific & Other 88,940 13 % 74,247 10 % 14,693 20 % Total $ 664,294 100 % $ 717,301 100 % $ (53,007) (7) % Sales by geographic region United States $ 101,387 15 % $ 164,564 23 % $ (63,177) (38) % EMEA 50,794 8 % 61,730 9 % (10,936) (18) % China 181,812 27 % 255,619 36 % (73,807) (29) % Rest of APAC 330,183 50 % 234,591 32 % 95,592 41 % Rest of World 118 — % 797 — % (679) (85) % Total $ 664,294 100 % $ 717,301 100 % $ (53,007) (7) % 41 Table of Contents Total sales decreased for the year ended December 31, 2025 against the comparable prior year period in the Data Storage and Compound Semiconductor markets, partially offset by increases in the Scientific & Other and Semiconductor markets.
Nanosecond annealing provides Veeco with an opportunity to expand our laser annealing SAM for new advanced node logic and memory applications, including low thermal budget anneals for Gate-All-Around transistors and advanced 3D devices. The ongoing adoption of EUV Lithography for advanced node semiconductor manufacturing continues to drive demand for our Ion Beam Deposition LDD system for mask blanks.
Nanosecond annealing provides Veeco with an opportunity to expand our laser annealing SAM for new advanced node logic and memory applications, including low thermal budget anneals for Gate-All-Around transistors and advanced 3D devices. The ongoing adoption of EUV Lithography for advanced node semiconductor manufacturing continues to drive demand for our Ion Beam Deposition EUV system for mask blanks.
Refer to Note 10, “Commitments and Contingencies”, of the Notes to the Consolidated Financial Statements for further discussion related to our lease obligations. We believe that we have sufficient capital resources and cash flows from operations to support the above mentioned short-term obligations. Critical Accounting Estimates Our discussion and analysis of our financial condition and results of operations are based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States.
Refer to Note 10, “Commitments and Contingencies”, of the Notes to the Consolidated Financial Statements for further discussion related to our lease obligations. We believe that we have sufficient capital resources and cash flows from operations to support the above mentioned short-term obligations. 45 Table of Contents Critical Accounting Estimates Our discussion and analysis of our financial condition and results of operations are based upon our Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States.
The following discussion contains forward-looking statements and should also be read in conjunction with the cautionary statement set forth at the beginning of this Form 10-K. The following section generally discusses 2024 and 2023 items and year-to-year comparisons between 2024 and 2023.
The following discussion contains forward-looking statements and should also be read in conjunction with the cautionary statement set forth at the beginning of this Form 10-K. The following section generally discusses 2025 and 2024 items and year-to-year comparisons between 2025 and 2024.
We are also evaluating other pronouncements recently issued but not yet adopted, including ASU 2023-09 and ASU 2024-03. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements. Refer to Note 1, “Significant Accounting Policies,” for additional information.
We are also evaluating other pronouncements recently issued but not yet adopted, including ASU 2024-03. The adoption of these pronouncements is not expected to have a material impact on our consolidated financial statements. Refer to Note 1, “Significant Accounting Policies,” for additional information.
We address the Scientific & Other market with several technologies, including MBE, ALD, MOCVD, Wet Processing, and IBD/IBE, which support scientific, optical coating and other applications, and sales in this market declined slightly in 2024 from the prior year. 34 Table of Contents Results of Operations Years Ended December 31, 2024 and 2023 The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2024 and 2023 and the period-over-period dollar and percentage changes for those line items.
We address the Scientific & Other market with several technologies, including MBE, ALD, MOCVD, Wet Processing, and IBD/IBE, which support scientific, optical coating and other applications, and sales in this market increased slightly in 2025 from the prior year. 40 Table of Contents Results of Operations Years Ended December 31, 2025 and 2024 The following table presents revenue and expense line items reported in our Consolidated Statements of Operations for 2025 and 2024 and the period-over-period dollar and percentage changes for those line items.
Veeco’s technologies are at the forefront of enabling new technical innovations in the manufacture of high-performance AI chips and High-Bandwidth Memory (“HBM”). We continue to invest in new technologies to expand our SAM to a broad range of new applications. Semiconductor revenue increased by 13% in 2024 from the prior year, comprising 65% of total revenue.
Veeco’s technologies are at the forefront of enabling new technical innovations in the manufacture of high-performance AI chips and High-Bandwidth Memory (“HBM”). We continue to invest in new technologies to expand our SAM to a broad range of new applications. Semiconductor revenue increased by 2% in 2025 from the prior year, comprising 72% of total revenue.
As a result, growth of the WFE market is forecasted to keep pace with long-term growth of the Semiconductor industry, which we believe should benefit semiconductor capital equipment providers, including Veeco. Our strategy of investing in advanced logic and memory has enabled our Semiconductor business to outperform WFE growth for four consecutive years.
As a result, growth of the WFE market is forecasted to keep pace with long-term growth of the Semiconductor industry, which we believe should benefit semiconductor capital equipment providers, including Veeco. Our strategy of investing in advanced logic and memory has enabled our Semiconductor business to continue to grow.
Leading logic and memory customers expect EUV and High-Numerical Aperture (“High-NA”) lithography to be integral to their future roadmaps, which our Ion Beam Deposition technology is a key enabler of.
Leading logic and memory customers expect EUV and High Numerical Aperture (“High-NA”) lithography to be integral to their future roadmaps, with our Ion Beam Deposition technology serving as a key enabler.
We generally do not enter into purchase commitments extending beyond one year. At December 31, 2024, we have $18.7 million of offsetting supplier deposits that will be applied against these purchase commitments.
We generally do not enter into purchase commitments extending beyond one year. At December 31, 2025, we have $9.8 million of offsetting supplier deposits that will be applied against these purchase commitments.
At December 31, 2024 and 2023, cash and cash equivalents of $45.1 million and $46.8 million, respectively, were held outside the United States. As of December 31, 2024, we had $21.2 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided.
At December 31, 2025 and 2024, cash and cash equivalents of $23.6 million and $45.1 million, respectively, were held outside the United States. As of December 31, 2025, we had $25.6 million of accumulated undistributed earnings generated by our non-U.S. subsidiaries for which the U.S. repatriation tax has been provided.
Approximately $9.6 million of undistributed earnings would be subject to foreign withholding taxes if distributed back to the United States and we accrued $1.2 million for foreign withholding taxes for the undistributed earnings. We believe that our projected cash flow from operations, combined with our cash and short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our convertible senior notes, purchase commitments, and payments required under our operating leases. 37 Table of Contents A summary of the cash flow activity for the year ended December 31, 2024 and 2023 is as follows: Cash Flows from Operating Activities Year Ended December 31, 2024 2023 (in thousands) Net income (loss) $ 73,714 $ (30,368) Non-cash items: Depreciation and amortization 25,143 24,966 Non-cash interest expense 1,257 1,118 Deferred income taxes (8,729) (2,211) Share-based compensation expense 35,879 28,558 Loss on extinguishment of debt — 97,091 Asset impairment 28,131 — Impairment of equity investment 404 — Provision for bad debts — 316 Change in contingent consideration (21,242) 701 Changes in operating assets and liabilities (70,742) (58,497) Net cash provided by (used in) operating activities $ 63,815 $ 61,674 Net cash provided by operating activities was $63.8 million for the year ended December 31, 2024 and was due to net income of $73.7 million and adjustments for non-cash items of $60.8 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $70.7 million.
Approximately $12.3 million of undistributed earnings would be subject to foreign withholding taxes if distributed back to the United States and we accrued $1.1 million for foreign withholding taxes for the undistributed earnings. We believe that our projected cash flow from operations, combined with our cash and short-term investments, will be sufficient to meet our projected working capital requirements, contractual obligations, and other cash flow needs for the next twelve months, including scheduled interest payments on our convertible senior notes, purchase commitments, and payments required under our operating leases. 43 Table of Contents A summary of the cash flow activity for the year ended December 31, 2025 and 2024 is as follows: Cash Flows from Operating Activities For the year ended December 31, 2025 2024 (in thousands) Net income $ 35,390 $ 73,714 Non-cash items: Depreciation and amortization 20,020 25,143 Non-cash interest expense 1,118 1,257 Deferred income taxes (2,982) (8,729) Share-based compensation expense 37,047 35,879 Asset impairment — 28,131 Impairment of equity investment — 404 Change in contingent consideration (925) (21,242) Changes in operating assets and liabilities (20,175) (70,742) Net cash provided by (used in) operating activities $ 69,493 $ 63,815 Net cash provided by operating activities was $69.5 million for the year ended December 31, 2025 and was due to net income of $35.4 million and adjustments for non-cash items of $54.3 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $20.2 million.
There is a yearly commitment fee of 25 to 35 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility. Contractual Obligations and Commitments We have commitments under certain contractual arrangements to make future payments for goods and services, including purchase obligations of $177.4 million as of December 31, 2024 for inventory used in the manufacture of our products, as well as equipment and project materials used to support research and development activities.
There is a yearly commitment fee of 20 to 30 basis points, based on the Company’s secured net leverage ratio, charged on the unused portion of the Facility. In connection with the Merger, the convertible senior notes will be assumed by Axcelis. Contractual Obligations and Commitments We have commitments under certain contractual arrangements to make future payments for goods and services, including purchase obligations of $150.8 million as of December 31, 2025 for inventory used in the manufacture of our products, as well as equipment and project materials used to support research and development activities.
These initial systems are being evaluated for advanced memory applications, such as DRAM bitline. 33 Table of Contents In Advanced Packaging, our Wet Processing systems are used for several applications, and we continue to see strong demand driven by Heterogenous Integration and 3D Packaging for AI.
These initial systems are being evaluated for advanced memory applications, such as DRAM bitline. In Advanced Packaging, we have seen significant growth in our business year-over-year. Our Wet Processing systems are used for several applications, and we continue to see strong demand driven by Heterogenous Integration and 3D Packaging for AI and high-performance computing.
Included within the Rest of APAC region for the year ended December 31, 2024 were sales in Taiwan and Japan of $115.3 million and $67.4 million, respectively, while sales within Rest of APAC region for the year ended December 31, 2023 included sales in Japan, Taiwan, and Singapore of $74.7 million, $62.7 million, and $32.2 million, respectively.
Included within the Rest of APAC region for the year ended December 31, 2025 were sales in Taiwan and Japan of $178.8 million and $69.0 million, respectively, while sales within Rest of APAC region for the year ended December 31, 2024 included sales in Taiwan and Japan of $115.3 million and $67.4 million, respectively.
In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate. Gross Profit In 2024, gross profit increased compared to 2023 primarily due to an increase in sales volume, partially offset by decreased gross margins.
In light of the global nature of our business, we are impacted by conditions in the various countries in which we and our customers operate, including the recent tariff and trade dynamics. Gross Profit In 2025, gross profit decreased compared to 2024 primarily due to a decrease in sales volume and gross margins.
Sales in the Semiconductor industry are estimated to have increased year-over-year in 2024 to around $650 billion dollars. Looking ahead, industry analysts are forecasting long-term growth of the industry, driven by secular growth trends such as artificial intelligence, high-performance computing, mobile connectivity, and the electrification of the automotive industry.
Looking ahead, industry analysts are forecasting long-term growth of the industry, driven by secular growth trends such as artificial intelligence, high-performance computing, mobile connectivity, and the electrification of the automotive industry.
This increase was driven by our Laser Annealing business with both leading and mature node customers. Our laser annealing solutions continue to gain acceptance at advanced logic nodes, highlighted by recent order activity involving both new and existing customers. In 2024, we received laser annealing orders from, and shipped systems to several leading-edge logic customers, including for customers’ Gate-All-Around processes.
This increase was driven by our Laser Annealing business with both leading and mature node customers. Our laser annealing solutions continue to gain acceptance at advanced logic nodes, highlighted by recent order activity involving both new and existing customers.
By geography, sales increased in the China, and Rest of APAC regions, partially offset by a decrease in the EMEA region.
By geography, sales decreased in the China, U.S., and EMEA regions, partially offset by an increase in the Rest of APAC Region.
The 2023 income tax expense of $2.0 million was primarily comprised of 1) a $16.2 million income tax expense related to pre-tax income from operations, and 2) a $2.0 million income tax expense related to share-based compensation, partially offset by 3) a $7.5 million income tax benefit related to Foreign-Derived Intangible Income, 4) a $7.7 million income tax benefit associated with research and development tax credits, and 5) a $1.0 million income tax benefit associated with the loss on extinguishment of convertible notes under Section 249 of the Internal Revenue Code of 1986, as amended (Section 249). Liquidity and Capital Resources Our cash and cash equivalents, restricted cash, and short-term investments are as follows: December 31, December 31, 2024 2023 (in thousands) Cash and cash equivalents $ 145,595 $ 158,781 Restricted cash 224 339 Short-term investments 198,719 146,664 Total $ 344,538 $ 305,784 A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar.
The 2024 income tax benefit was primarily attributed to 1) $12.2 million of income tax benefits associated with asset impairments, 2) a $7.9 million income tax benefit related to research and development tax credits, and 3) a $5.1 million income tax benefit related to Foreign-Derived Intangible Income, partially offset by 4) a $20.3 million income tax expense related to pre-tax income from operations. Liquidity and Capital Resources Our cash and cash equivalents, restricted cash, and short-term investments are as follows: December 31, December 31, 2025 2024 (in thousands) Cash and cash equivalents $ 163,466 $ 145,595 Restricted cash — 224 Short-term investments 226,763 198,719 Total $ 390,229 $ 344,538 A portion of our cash and cash equivalents is held by our subsidiaries throughout the world, frequently in each subsidiary’s respective functional currency, which is typically the U.S. dollar.
At December 31, 2024, outstanding bank guarantees and letters of credit totaled $18.1 million and unused bank guarantees and letters of credit of $21.6 million were available to be drawn upon. 39 Table of Contents Lease Obligations As of December 31, 2024, our operating lease obligation was $53.1 million relating to various operating lease arrangements for certain facilities.
At December 31, 2025, outstanding bank guarantees and letters of credit totaled $2.4 million and unused bank guarantees and letters of credit of $40.6 million were available to be drawn upon. Lease Obligations As of December 31, 2025, our future minimum lease payments was $48.9 million relating to various operating lease arrangements for certain facilities.
The Company has no immediate plans to draw down on the facility, which expires in December of 2026. Interest under the facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 150 to 225 basis points, if drawn.
Interest under the facility is variable based on the Company’s secured net leverage ratio and is expected to bear interest based on SOFR plus a range of 125 to 200 basis points, if drawn.
The cash used in investing activities during the year ended December 31, 2023 was attributable to net cash used in the acquisition of Epiluvac, and capital expenditures, partially offset by changes in net investment activity. 38 Table of Contents Cash Flows from Financing Activities Year Ended December 31, 2024 2023 (in thousands) Settlement of equity awards, net of withholding taxes $ (10,761) $ (6,391) Contingent consideration payment (1,818) (2,500) Proceeds from issuance of 2029 Notes, net of issuance costs — 223,202 Extinguishment of Convertible Notes — (218,991) Net cash provided by (used in) financing activities $ (12,579) $ (4,680) The cash used in financing activities for the year ended December 31, 2024 was related to cash used to settle taxes related to employee equity programs and a contingent consideration payment related to the Epiluvac acquisition, partially offset by cash received under the Employee Stock Purchase Plan.
The cash used in investing activities during the year ended December 31, 2024 was primarily attributable to net cash used for capital expenditures, and net investment activity, partially offset by proceeds from the sale of productive assets. 44 Table of Contents Cash Flows from Financing Activities For the year ended December 31, 2025 2024 (in thousands) Settlement of equity awards, net of withholding taxes $ (4,355) $ (10,761) Debt issuance costs (885) — Repayment of convertible debt (5,229) — Contingent consideration payment — (1,818) Net cash provided by (used in) financing activities $ (10,469) $ (12,579) The cash used in financing activities for the year ended December 31, 2025 was related to cash used to settle taxes related to employee equity programs, settlement of the 2027 Notes, and debt issuance costs associated with the execution of the Fourth Amendment of the Loan and Security Agreement, partially offset by cash received under the Employee Stock Purchase Plan.
The 2024 income tax benefit was primarily attributed to 1) $12.2 million of income tax benefits associated with asset impairments, 2) a $7.9 million income tax benefit related to research and development tax credits, and 3) a $5.1 million income tax benefit related to Foreign-Derived Intangible Income, partially offset by 4) a $20.3 million income tax expense related to pre-tax income from operations.
The 2025 income tax expense was primarily attributed to 1) a $8.3 million income tax expense associated with pre-tax income from operations, 2) a $3.1 million income tax expense related to adjustments made for share-based compensation, and 3) a $1.4 million income tax expense related to non-deductible merger costs, partially offset by 4) a $5.7 million income tax benefit related to foreign-derived intangible income, and 5) a $3.6 million tax benefit associated with research and development tax credits.
The net cash used in financing activities for the year ended December 31, 2023 was related to the partial repurchase of the 2025 Notes and 2027 Notes, repayment of the 2023 Notes, a contingent consideration payment related to the Epiluvac acquisition, as well as cash used to settle taxes related to employee equity programs, partially offset by proceeds from issuance of the 2029 Notes. Convertible Senior Notes and Revolving Credit Facility We have $26.5 million outstanding principal balance of 3.50% convertible senior notes that bear interest at a rate of 3.50% per year, payable semiannually in arrears on January 15 and July 15 of each year, and mature on January 15, 2025, unless earlier purchased by the Company, redeemed, or converted.
The cash used in financing activities for the year ended December 31, 2024 was related to cash used to settle taxes related to employee equity programs and a contingent consideration payment related to the Epiluvac acquisition, partially offset by cash received under the Employee Stock Purchase Plan. Convertible Senior Notes and Revolving Credit Facility We have $230.0 million outstanding principal balance of convertible senior notes that bear interest at a rate of 2.875% per year, payable semiannually in arrears on June 1 and December 1 of each year, and mature on June 1, 2029, unless earlier purchased by the Company, redeemed, or converted. We believe that we have sufficient capital resources and cash flows from operations to support scheduled interest payments on this debt.
The changes in operating assets and liabilities were largely attributable to increases in inventories largely related to evaluation systems at customer facilities, contract assets, prepaid expenses and other current assets, and decreases in accounts payable, and contract liabilities. Cash Flows from Investing Activities Year Ended December 31, 2024 2023 (in thousands) Capital expenditures $ (18,113) $ (27,930) Changes in investments, net (48,467) 4,973 Acquisitions of businesses, net of cash acquired — (30,373) Proceeds from the sale of productive assets 2,033 — Net cash provided by (used in) investing activities $ (64,547) $ (53,330) The cash used in investing activities during the year ended December 31, 2024 was primarily attributable to net cash used for capital expenditures, and net investment activity, partially offset by proceeds from the sale of productive assets.
The changes in operating assets and liabilities were largely attributable to an increase in inventories largely related to higher work-in-process and evaluation systems at customer facilities, an increase in contract assets, and a decrease in contract liabilities. Cash Flows from Investing Activities For the year ended December 31, 2025 2024 (in thousands) Capital expenditures $ (16,200) $ (18,113) Changes in investments, net (25,278) (48,467) Proceeds from the sale of productive assets — 2,033 Net cash provided by (used in) investing activities $ (41,478) $ (64,547) The cash used in investing activities during the year ended December 31, 2025 was primarily attributable to net cash used for capital expenditures and net investment activity.
The changes in operating assets and liabilities were largely attributable to an increase in inventories largely related to higher work-in-process and evaluation systems at customer facilities, an increase in contract assets, and a decrease in contract liabilities. Net cash provided by operating activities was $61.7 million for the year ended December 31, 2023 and was due to net loss of $30.4 million and adjustments for non-cash items of $150.5 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $58.5 million.
The changes in operating assets and liabilities were largely attributable to an increase in inventories and accounts receivable, partially offset by an increase in contract liabilities. Net cash provided by operating activities was $63.8 million for the year ended December 31, 2024 and was due to net income of $73.7 million and adjustments for non-cash items of $60.8 million, partially offset by a decrease in cash flow from changes in operating assets and liabilities of $70.7 million.
Discussions of 2023 items and year-to-year comparisons between 2023 and 2022 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed on February 16, 2024. Executive Summary We are an innovative manufacturer of semiconductor process equipment.
Discussions of 2024 items and year-to-year comparisons between 2024 and 2023 that are not included in this Form 10-K can be found in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part II, Item 7 of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed on February 14, 2025. Merger with Axcelis Technologies, Inc. On September 30, 2025, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Axcelis Technologies, Inc., a Delaware corporation (“Axcelis”), and Victory Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Axcelis (“Merger Sub”).
Given the uncertainty regarding the impacts on our business resulting from the general macroeconomic environment, we are focused on the proactive management of expenses. Amortization Expense Amortization expense decreased in 2024 compared to 2023 primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized in 2023. Asset Impairment During 2024, we recorded a non-cash impairment charge of $28.1 million related to intangible assets of our SiC technology acquired from Epiluvac in 2023, due to our market penetration not meeting expectations. Other Operating Expense (Income), Net Net other operating income in 2024 was primarily due to a $21.2 million reduction in the expected earn-out payments to be made to the previous shareholders of Epiluvac, as well as proceeds from the sale of productive assets . Interest Income (Expense) For the year ended December 31, 2024, we recorded net interest income of $1.9 million, compared to $1.2 million of net interest expense for the prior year.
Research and development expenses decreased in 2025 compared to 2024 primarily due to personnel-related and operating-related expenses as part of our efforts to manage costs. Selling, General, and Administrative Selling, general, and administrative expenses remained consistent for the year ended December 31, 2025 against the comparable prior period. Amortization Expense Amortization expense decreased in 2025 compared to 2024 primarily due to changes in amortization expense to reflect expected cash flows of certain intangible assets, as well as certain other intangible assets becoming fully amortized and the full impairment of the Epiluvac related intangibles in 2024. Merger Costs During the year ended December 31, 2025, we incurred approximately $8.9 million in legal, accounting, consulting fees and employee-related costs in connection with the proposed Merger. Asset Impairment During 2024, we recorded a non-cash impairment charge of $28.1 million related to intangible assets of our SiC technology acquired from Epiluvac in 2023, due to our market penetration not meeting expectations. Other Operating Expense (Income), Net Other operating income for the year ended December 31, 2025 was $0.9 million, primarily comprised of a reduction in the expected earn-out payment to the previous shareholders of Epiluvac.
We also shipped and recognized revenue on our first NSA system to a leading logic customer in the fourth quarter. In the memory market, we continue to ship systems to a Tier 1 customer for high volume production of HBM and advanced DRAM devices.
In 2025, we received laser annealing orders from, and shipped systems to several leading-edge logic customers and had multiple repeat orders from a DRAM customer. In the memory market, we continue to ship systems to Tier 1 customers for high volume production of HBM and advanced DRAM devices.
Deferred tax assets and liabilities are adjusted to reflect the effects of enacted changes in tax rates, laws and status, including changes in tax incentives. Recent Accounting Pronouncements We adopted ASU 2020-06 effective January 1, 2022 and ASU 2023-07 effective December 31, 2024.
Deferred tax assets and 46 Table of Contents liabilities are adjusted to reflect the effects of enacted changes in tax rates, laws and status, including changes in tax incentives. Recent Accounting Pronouncements We adopted ASU 2020-06 Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity effective January 1, 2022, ASU 2023-09 Improvements to Income Tax Disclosures (Topic 740) effective December 31, 2024, ASU 2024-04 Debt – Debt with Conversion and Other Options (Subtopic 470-20) effective June 30, 2025.
While our growth strategy is predominately focused on advanced node logic and memory, LSA shipments to mature node customers have continued to increase in 2023 and 2024, predominantly driven by new greenfield fabs and capacity additions in China. We have two next generation laser annealing systems under evaluation at Tier 1 foundry and logic customers.
Our growth strategy remains predominately focused on advanced node logic and memory customers. We have two next generation laser annealing systems under evaluation at Tier 1 foundry and logic customers. We also shipped and recognized revenue on our NSA500 tool to a logic customer in 2025.
We expect our gross margins to fluctuate each period due to product mix and other factors. Research and Development The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives.
We expect higher costs in future periods as we incur tariffs on imported materials from overseas suppliers, as well as higher costs from domestic suppliers incurring tariffs on their imports. Research and Development The markets we serve are characterized by continuous technological development and product innovation, and we invest in various research and development initiatives to maintain our competitive advantage and achieve our growth objectives.
For items that are not sold separately, we estimate SSPs generally using an expected cost plus margin approach.
The SSPs are determined based on the prices at which we separately sell systems, upgrades, components, spare parts, installation, maintenance, and service plans. For items that are not sold separately, we estimate SSPs generally using an expected cost plus margin approach.
Gross margins decreased principally due to unfavorable product mix of sales and higher service costs.
Gross margins decreased principally due to unfavorable product mix of sales and higher production and tariff related costs. We expect our gross margins to fluctuate each period due to product mix and other factors. Additionally, other factors will cause our gross margins to fluctuate each period.
After two years of slow order activity driven by consumer markets, we are beginning to see an increase in quoting and order activity from IDM’s, foundries, and OSAT’s driven by capacity expansions for AI and mobile markets. Looking ahead, we anticipate seeing growth in leading-edge investment driven by new nodes and AI-related demand, including investment in Gate-All-Around nodes, High-Bandwidth Memory, and 3D packaging for AI.
We are seeing an uptick in the order activity from several OSAT customers driven by AI and consumer markets recovery. Looking ahead, we anticipate seeing growth in the semiconductor market in leading-edge investment driven by new nodes and AI-related demand, including investment in Gate-All-Around nodes, High-Bandwidth Memory, and 3D packaging for AI. Veeco also serves the Compound Semiconductor market with a broad portfolio of technologies, including Wet Processing, MOCVD, MBE and Ion Beam, for Power Electronics, Photonics, and 5G RF applications.
The increase in net interest income was primarily related to an increase of interest income of approximately $2.3 million due to a higher interest rate environment for 2024 compared to 2023. 36 Table of Contents Additionally, the Company had a decrease of interest expense of approximately $0.7 million due to a reduction in convertible note and bank guarantee interest expenses. Other Income (Expense) For the year ended December 31, 2023, we recorded a loss on extinguishment of approximately $97.1 million related to the repurchase and retirement of approximately $206.0 million aggregate principal amount of our 2025 and 2027 Notes. Income Taxes Our income tax benefit for the year ended December 31, 2024, was $4.9 million, compared to income tax expense of $2.0 million for the prior year.
Additionally, the company had an increase of approximately $0.6 million of interest income due to a higher average cash balances for 2025 compared to 2024. Income Taxes Our income tax expense for the year ended December 31, 2025, was $4.0 million, compared to income tax benefit of $4.9 million for the prior year.
Our product roadmap is well positioned as the industry adopts next-generation High-NA EUV lithography, and we are expanding our EUV related business to new mask blank applications. We also have two Ion Beam Deposition “IBD300” systems under evaluation at leading memory customers.
Our product roadmap is well positioned as the industry adopts next-generation High-NA EUV lithography, and we are expanding our EUV related business to EUV pellicles which are increasingly 39 Table of Contents being used to improve the productivity of EUV steps.
Management uses judgements in identifying performance obligations, determining stand-alone selling price (“SSP”) for each distinct performance obligation and allocating consideration from an arrangement to the individual performance obligations based on the SSP. The SSPs are determined based on the prices at which we separately sell systems, upgrades, components, spare parts, installation, maintenance, and service plans.
Management uses judgements in identifying performance obligations, determining stand-alone selling price (“SSP”) for each distinct performance obligation, allocating consideration from an arrangement to the individual performance obligations based on the SSP, determining when transfer of control occurs to the customer, and estimating potential variable consideration including the probability that a significant reversal in the amount of cumulative revenue recognized will not occur.
Our IBD300 system provides Veeco with another opportunity to expand our SAM to advanced node applications where low resistance films are critical.
Our IBD-EUV system is used to form the high transparency membrane used in pellicles. We have two Ion Beam Deposition (“IBD300”) systems under evaluation at leading DRAM memory customers, which we have extended the evaluation into 2026. Our IBD300 system provides Veeco with another opportunity to expand our SAM to advanced node applications where low resistance films are critical.
We evaluate usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors.
We evaluate usage requirements by analyzing historical usage, anticipated demand, alternative uses of materials, and other qualitative factors. Unanticipated changes in demand for our products may require a write down of inventory that could materially affect our operating results. Income Taxes We estimate our income taxes in each of the jurisdictions in which we operate.
In the fourth quarter, we announced over $50 million in orders for our Wet Processing systems from a leading foundry, a HBM manufacturer, and OSATs. Our Advanced Packaging lithography systems are used for packaging applications such as fan out wafer level packaging and other advanced packaging solutions.
Our Advanced Packaging lithography systems are used for packaging steps such Cu pillar and microbumps used in fan out wafer level packaging and other 2.5 and 3D advanced packaging solutions.
To learn more about Veeco’s systems and service offerings, visit www.veeco.com. Veeco executed well during 2024, accomplishing a number of milestones, including: ● Solidly executing our multi-year growth strategy highlighted by several strategic wins.
To learn more about Veeco’s systems and service offerings, visit www.veeco.com. Veeco executed well during 2025, and accomplished a number of milestones, including: ● Accomplished year-on-year revenue semiconductor market growth, accounting for 72% of total Company revenue ● Shipped a Laser Spike Annealing (“LSA”) system to a second Tier 1 memory customer for evaluation in its advanced DRAM R&D group.
As a result, we expect an approximate $60 to $70 million reduction in revenue in our Data Storage business in 2025. Sales in the Scientific & Other market are largely driven by sales to governments, universities, and research institutions.
Orders received in the third and fourth quarter of 2025 for our ion beam and wet processing equipment from demand for cloud and AI Data Centers, will drive revenue growth in 2026, principally in the second half. Sales in the Scientific & Other market are largely driven by sales to governments, universities, and research institutions.